Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC L-threonine, N-[[[1S-3-amino-1-[3-[1R-1-amino-2-hydroxyethyl]-1,2,4-oxadiazol-5-yl]-3-oxopropyl] | 1673534-76-3 | 360.32 | C12H20N6O7 | 100 MG
SDP

Catalog No. 5000211835
Encompass_Preferred

CA-170 is a small-molecule dual inhibitor of the immune checkpoints VISTA and PD-L1 developed for preclinical research. It modulates T-cell proliferation and effector functions suppressed by PD-L1/L2 and VISTA, and is used to study immune checkpoint pathways in vitro and in vivo.

  • Dual inhibitor of VISTA and PD-L1
  • Orally active small-molecule suitable for preclinical studies
  • Modulates T-cell proliferation and effector functions
  • Defined chemical properties to support reproducibility
  • Storage recommendations provided for powder and solutions
  • Intended for research use only

Catalog No. 50-002-11835 Supplier Medchemexpress LLC Supplier No. HY101093100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

CA-170 is a small-molecule dual inhibitor of the immune checkpoints VISTA and PD-L1 developed for preclinical research. It modulates T-cell proliferation and effector functions suppressed by PD-L1/L2 and VISTA, and is used to study immune checkpoint pathways in vitro and in vivo.

  • Dual inhibitor of VISTA and PD-L1
  • Orally active small-molecule suitable for preclinical studies
  • Modulates T-cell proliferation and effector functions
  • Defined chemical properties to support reproducibility
  • Storage recommendations provided for powder and solutions
  • Intended for research use only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.